key: cord-1042264-a5f6oez2
authors: DARA, Naghi; SHARIFI, Naghmeh; GHANBARI BOROUJENI, Masoud; HOSSEINI, Amirhossein; SAYYARI, Aliakbar
title: COVID-19 pneumonia in a child with hepatic encephalopathy: A case study
date: 2021
journal: Iran J Child Neurol
DOI: 10.22037/ijcn.v15i1.30879
sha: 04e905310f50d6e1a48a009cfb7599b92838192e
doc_id: 1042264
cord_uid: a5f6oez2

Coronavirus disease 2019 (COVID-19) is caused by the seventh coronavirus, known as the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2). Children often have milder diseases than adults with very rare mortality. Gastrointestinal manifestations and a mild increase in liver enzymes have been reported in 8.8% to 53% of COVID-19 cases. However, liver failure is extremely rare and has not been reported so far in the literature. The prevalence of comorbidities is not clear in children with COVID-19. Here, we reported a fatal case of simultaneous pneumonia secondary to SARS-CoV-2and acute liver failure in a 14-year-old boy with liver cirrhosis.

Iran J Child Neurol. Winter 2021 Vol. 15 No. 1 RNA RT-PCR, a chest CT scan is useful in the early detection of pulmonary involvements before the onset of symptoms (5) . Several studies reported gastrointestinal symptoms such as nausea, vomiting, diarrhea, and liver function abnormalities during the course of COVID-19 (6) . This is a very rare presentation of liver involvement in COVID-19.

The interaction between COVID-19 and liver function is still unclear, and more investigations should be carried out to clarify this interaction.

Here, we presented a fatal case of superimposed COVID-19 pneumonia on chronic liver cirrhosis with a dominant feature of encephalopathy and acute liver failure.

In this report, we realized that a pediatric gastroenterologist and a pediatric neurologist need to consider liver involvement as a primary presentation of COVID-19. Moreover, a physician should consider acute liver failure in a patient with chronic liver disease as a complication of this viral infection. The first complete blood count (CBC) showed anemia, lymphopenia, and thrombocytopenia. 

Several studies documented a mild increase in serum aminotransferase (14-53%) in many COVID-19 patients (6) . This condition is similar to the past SARS outbreak, with liver impairments in up to 60% of infected patients (7) . Furthermore, the prevalence of chronic liver disease is about 

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet

Liver and kidney injuries in COVID-19 and their effects on drug therapy

Clinical characteristics of coronavirus disease 2019 in China

Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults

Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study

Clinical Characteristics and Outcomes of COVID-19 Among Patients with

SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases

The clinical manifestations and management of COVID-19-related liver injury

Liver injury in COVID-19: management and challenges

Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper

All sources of support, including pharmaceutical and industry support, that require acknowledgment;No support, no acknowledgment

All the authors equally contributed to the preparation of the manuscript.

None